Skip to main content

Table 2 Diagnostic performance on a patient basis for the detection of lymph node metastasis with pathology as reference. Data accuracy data from any comparative index test(s) are shown in parenthesis

From: PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review

Ref

Author

LNM (%)

Sens

(%)

Spec

(%)

PPV

(%)

NPV

(%)

Comparative index tests

1

Budaus et al. [16]

40

33

100

100

69

None

2

Herlemann et al. [17]

NR

91

67

83

80

None

3

Maurer et al. [18]

32

66 (44)

99 (85)

96 (58)

86 (77)

CT

4

Van Leeuwen et al. [19]

37

64

95

88

82

None

5

Uprimny et al. [20]

37

61

94

85

81

None

6

Gupta et al. [21]

58

100 (57)

80 (80)

88 (80)

100 (57)

MRI

7

Obek et al., [22]

29

53 (25)

86 (76)

61.5 (NR)

81 (NR)

MRI/CT

8

Zhang et al. [23]

36

93 (96)

96 (96)

93 (88)

96 (100)

mpMRI

9

Park et al. [24]

9

100

87

43

100

None

10

Van Leeuwen et al. [25]

36

53 (14)

88 (99)

71 (81)

76 (67)

DW-MRI

11

Gorin et al. [26]

28

71

89

71

89

None

12

Cantiello et al. [27]

35

88

100

100

94

None

13

Thalgott et al. [28]a

34

60

100

100

83

None

14

Berger et al. [29]

4

50 (NR)

92 (NR)

20 (NR)

98 (NR)

mpMRI

15

Gupta et al. [30]

39

78

93

88

87

None

16

Yaxley et al. [31]

26

38

93

68

81

None

17

Yilmaz et al. [32]

20

100 (100)

100 (38)

100 (29)

100 (29)

mpMRI

18

Petersen et al. [33]b

65

23–39 (8;37)

100 (100;83)

100 (100;80)

41–47 (37;42)

CT/MRI; DW-MRI

  1. aPatients with equivocal PSMA scans were consider negative for lymph node metastases. bSensitivity analysis were performed where intermediate findings are calculated as either benign or malignant). Abbreviations. LNM lymph node metastasis